1. Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf).
2017;5(2):138-47. doi: 10.1093/gastro/gox013.
2. Butterworth RF. Hepatic encephalopathy in alcoholic
cirrhosis. Handb Clin Neurol. 2014;125:589-602. doi:
10.1016/b978-0-444-62619-6.00034-3.
3. Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of
hepatic encephalopathy: role of ammonia and systemic
inflammation. J Clin Exp Hepatol. 2015;5(Suppl 1):S7-20. doi:
10.1016/j.jceh.2014.06.004.
4. Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese
S, Taylor-Robinson SD, et al. Hepatic encephalopathy:
novel insights into classification, pathophysiology and
therapy. J Hepatol. 2020;73(6):1526-47. doi: 10.1016/j.
jhep.2020.07.013.
5. Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy:
current challenges and future prospects. Hepat Med.
2018;10:1-11. doi: 10.2147/hmer.s118964.
6. Suraweera D, Sundaram V, Saab S. Evaluation and
management of hepatic encephalopathy: current status and
future directions. Gut Liver. 2016;10(4):509-19. doi: 10.5009/
gnl15419.
7. Elwir S, Rahimi RS. Hepatic encephalopathy: an update on
the pathophysiology and therapeutic options. J Clin Transl
Hepatol. 2017;5(2):142-51. doi: 10.14218/jcth.2016.00069.
8. Wijdicks EF. Hepatic encephalopathy. N Engl J Med.
2016;375(17):1660-70. doi: 10.1056/NEJMra1600561.
9. Askgaard G, Fleming KM, Crooks C, Kraglund F, Jensen CB,
West J, et al. Socioeconomic inequalities in the incidence
of alcohol-related liver disease: a nationwide Danish study.
Lancet Reg Health Eur. 2021;8:100172. doi: 10.1016/j.
lanepe.2021.100172.
10. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen
KD, et al. Hepatic encephalopathy in chronic liver disease:
2014 Practice Guideline by the American Association for
the Study of Liver Diseases and the European Association for
the Study of the Liver. Hepatology. 2014;60(2):715-35. doi:
10.1002/hep.27210.
11. Knott CS, Coombs N, Stamatakis E, Biddulph JP. All cause
mortality and the case for age specific alcohol consumption
guidelines: pooled analyses of up to 10 population-based
cohorts. BMJ. 2015;350:h384. doi: 10.1136/bmj.h384.
12. Kunzmann AT, Coleman HG, Huang WY, Berndt SI. The
association of lifetime alcohol use with mortality and
cancer risk in older adults: a cohort study. PLoS Med.
2018;15(6):e1002585. doi: 10.1371/journal.pmed.1002585.
13. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic
liver disease. Alcohol Res Health. 2003;27(3):209-19.
14. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver
cancer in the United States, 1999-2016: observational study.
BMJ. 2018;362:k2817. doi: 10.1136/bmj.k2817.
15. Khan A, Ayub M, Khan WM. Hyperammonemia is associated
with increasing severity of both liver cirrhosis and hepatic
encephalopathy. Int J Hepatol. 2016;2016:6741754. doi:
10.1155/2016/6741754.
)